Redwood Dermatology Sciences
1 clinical trials · Sponsor
◉ Watch Redwood Dermatology Sciences
| Record | Firm | Date |
|---|---|---|
| Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets (NCT03581591) | Redwood Dermatology Sciences | 2018-01-31 |
Track Redwood Dermatology Sciences automatically
Every clearance here is in the API, with alerts when new ones post.